Patient Characteristics
| Patient Number . | Age at Diagnosis (years) . | Stage at Diagnosis . | Time to First Relapse (months) . | Relapse Number . | Courses of Chemotherapy Before Vaccine* . | Disease Sites Before Treatment . |
|---|---|---|---|---|---|---|
| 1 | 9.3 | IV | 12 | 1 | 0 | Thoracic paraspinous mass, bone, bone marrow-151 |
| 2 | 13 | IV | 12 | 1 | 0 | Thoracic and lumbar-151paraspinous mass |
| 3 | 3.3 | IV | 16 | 2 | 2 | Right cervical and axillary nodes, bone, bone marrow-151 |
| 4 | 3.5 | IV | 14 | 1 | 0 | Left cervical node, bone marrow-151 |
| 5 | 7 | IV | 72 | 2 | 1 | Pleural, pulmonary nodules, bone marrow-151 |
| 6 | 11 months | II | 24 | 4 | 3 | Cervical nodes-151 |
| 7 | 11 | III | 39 | 2 | 0 | Thoracic nodes, bone marrow-151 |
| 8 | 3.5 | IV | 30 | 4 | 1 | Bone marrow-151 |
| 9 | 5.25 | IV | 9 | 1 | 1 | Bone, bone marrow-151 |
| 10 | 17 | III | 58 | 1 | 1 | Left cervical-151 retroperitoneal nodes |
| Patient Number . | Age at Diagnosis (years) . | Stage at Diagnosis . | Time to First Relapse (months) . | Relapse Number . | Courses of Chemotherapy Before Vaccine* . | Disease Sites Before Treatment . |
|---|---|---|---|---|---|---|
| 1 | 9.3 | IV | 12 | 1 | 0 | Thoracic paraspinous mass, bone, bone marrow-151 |
| 2 | 13 | IV | 12 | 1 | 0 | Thoracic and lumbar-151paraspinous mass |
| 3 | 3.3 | IV | 16 | 2 | 2 | Right cervical and axillary nodes, bone, bone marrow-151 |
| 4 | 3.5 | IV | 14 | 1 | 0 | Left cervical node, bone marrow-151 |
| 5 | 7 | IV | 72 | 2 | 1 | Pleural, pulmonary nodules, bone marrow-151 |
| 6 | 11 months | II | 24 | 4 | 3 | Cervical nodes-151 |
| 7 | 11 | III | 39 | 2 | 0 | Thoracic nodes, bone marrow-151 |
| 8 | 3.5 | IV | 30 | 4 | 1 | Bone marrow-151 |
| 9 | 5.25 | IV | 9 | 1 | 1 | Bone, bone marrow-151 |
| 10 | 17 | III | 58 | 1 | 1 | Left cervical-151 retroperitoneal nodes |
*Chemotherapy courses counted after relapse, before entry into study.
Source of tumor cells for vaccine.